RxDoctor Payments Data

Roger Bowles, MD

Internal Medicine · Littleton, CONPI 1063473965

Payments from drug & device makers

$6,397in general payments, 2019–2025

Across 382 payments — averaging $16.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$936
  • Pfizer$787
  • Johnson & Johnson$715
  • Amgen$615
  • AstraZeneca$527
  • Novo Nordisk$313
  • plus $3K from 30 others

What the payments were for

  • Food & beverage$6,383100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,397 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$142,473
Medicare patients
410
Services billed
1,822

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban135$163,173
OzempicSemaglutide33$39,415
JanuviaSitagliptin Phosphate21$23,297
NeurontinGabapentin11$21,079
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$13,761
Soliqua 100-33Insulin Glargine/Lixisenatide18$10,944
FarxigaDapagliflozin Propanediol11$8,410
Repatha SureclickEvolocumab11$6,074
SynthroidLevothyroxine Sodium79$6,018
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$5,294
Levothyroxine Sodium372$4,341
Butalbital-Aspirin-CaffeineButalbital/Aspirin/Caffeine15$3,522
Duloxetine Hcl59$2,993
Atorvastatin Calcium392$2,926
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen61$2,789

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$787$164,602169 claims
Novo NordiskOzempic$313$39,41533 claims
MerckJanuvia$226$23,29721 claims
AstraZenecaBreztri Aerosphere, Farxiga$527$22,17129 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$122$12,57429 claims
AbbVieSynthroid$936$6,01879 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,430 internal medicine providers in Colorado.

Other internal medicine in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →